Popular tags

BioNTech doses first patient in herpes vaccine candidate clinical trial

Biontech

Doses

First

Patient

Herpes

Vaccine

Candidate

Clinical

Trial

47Report
BioNTech doses first patient in herpes vaccine candidate clinical trial

BioNtech has dosed the first patient with its BNT163 herpes vaccine candidate designed to prevent genital lesions as part of a first-in-human Phase 1 clinical research study, the German vaccine maker said on Wednesday.

https://www.reuters.com/business/healthcare-pharmaceuticals/biontech-doses-first-patient-herpes-vaccine-candidate-clinical-trial-2022-12-21/

Similar news

Share
Report

Report this article here.